Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02600546 · ClinicalTrials.gov registry record
Evaluation of the Repeatability and Reproducibility of Corneal Epithelial Thickness Mapping With SD-OCT
A clinical trial of Repeatability & Reproducibility, sponsored by Optovue.
- Completed
- Registry status
- 62
- Enrollment target
- 1
- Study location
NCT02600546: Completed study of Repeatability & Reproducibility, sponsored by Optovue.
NCT02600546 is a study of Repeatability & Reproducibility that has completed, run by Optovue. The registered enrollment target is 62 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02600546, a study of Repeatability & Reproducibility, has completed, sponsored by Optovue.
- COMPLETED
- Registry status
- 62 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluate the repeatability and reproducibility of the RTVue-XR for measuring the total corneal thickness (pachymetry), the epithelial thickness, and the stromal thickness mapping in normal subjects and corneal patients.
Conditions Studied
Study Locations (1)
Texas
- Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2015-10 |
| Est. Completion | 2016-02 |
What the finished NCT02600546 record still lists
NCT02600546 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 62 participants, a relatively small participant target.
The record links to 1 condition, with Repeatability & Reproducibility appearing as the primary indexed condition, and to 0 interventions.
NCT02600546 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02600546 about?
NCT02600546 is a clinical study titled "Evaluation of the Repeatability and Reproducibility of Corneal Epithelial Thickness Mapping With SD-OCT". Evaluate the repeatability and reproducibility of the RTVue-XR for measuring the total corneal thickness (pachymetry), the epithelial thickness, and the stromal thickness mapping in normal subjects and corneal patients.
What is the current status of trial NCT02600546?
This trial is currently completed. The enrollment target is 62 participants. The study started on 2015-10. Estimated completion is 2016-02.
What conditions does trial NCT02600546 study?
This clinical trial studies the following conditions: Repeatability & Reproducibility.
Who is sponsoring clinical trial NCT02600546?
This trial is sponsored by Optovue, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02600546 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia